Power Law company profile

Kadmon

Biotech & Life Sciences · New York City, United States · Founded 2009 · IPO 2016 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.90B

Market cap · 2026

Revenue

$5.0M

Latest reported FY

Global footprint

Where Kadmon has talent and traffic

Web traffic by country

230 monthly visits
across markets

🇺🇸 United States87%

Top 1 markets shown

Patent intelligence

$31M patent portfolio · 51 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$31M

1.6% of market cap · 5.3× smaller than top peer Amicus Therapeutics ($164M)

51 active patent families

Where Kadmon innovates PharmacologyMolecular biologyHost diseaseEndocrinologyDisease

Above peer median on Strategic · Below peer median on Market

Quality vs same-sector peers

Kadmon on the five Patsnap quality dimensions

Kadmon in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Kadmon concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Kadmon and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Kadmon on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo